I see that MeDaVinci is up 17% today following a positive write-up in the Express on the change to Orogen Gold. Whoops!!
Well it makes my review published at the weekend a little ill timed, I bet the bulls are crying with laughter! However, in fairness to myself, I did point out that the shares would rise short term on the Orogen acquisition noise and PR. But, and this is a big but, I have concerns about this company in general. I guess this is the curse of a blogger, sometimes a review based on all the facts doesn't matter a damn, when private investors pile in on near term sentiment.
But new investors in MVC, please be careful of a "pump and dump", especially with a penny share! Don't just rely on newspaper tips!
Of course, I might be completely wrong on MVC and its going to be a ten bagger. Fair play if it does and good luck to holders. It just doesn't fit the Contrarian Investor uk risk profile. Funny, this AIM share game!
No comments:
Post a Comment